Related Experiment Video

Updated: Aug 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

[Anticoagulation with atrial fibrillation]

S Zellerhoff1, A Goette, P Kirchhof

  • 1Medizinische Klinik und Poliklinik C, Kardiologie und Angiologie, Kompetenznetz Vorhofflimmern, Universitätsklinikum Münster, Albert-Schweitzer-Strasse 33, 48149, Münster, Germany.

Herzschrittmachertherapie & Elektrophysiologie
|June 21, 2006
PubMed

Insights

Atrial fibrillation significantly increases stroke risk. Continuous oral anticoagulation, particularly with vitamin K antagonists, is crucial for preventing over half of these ischemic strokes when properly monitored.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Context:

  • Atrial fibrillation (AF) is a major risk factor for ischemic stroke, accounting for 20-25% of all strokes.
  • Individual stroke risk in AF patients ranges from 2% to 14% annually, necessitating risk stratification.
  • Current guidelines recommend continuous oral anticoagulation for AF patients with at least one additional thromboembolic risk factor.

Purpose:

  • To review the role of oral anticoagulation in preventing stroke in atrial fibrillation patients.
  • To discuss the efficacy and monitoring requirements of vitamin K antagonists.
  • To highlight the potential of novel anticoagulants.

Summary:

  • Oral anticoagulation, primarily with vitamin K antagonists (VKAs), is highly effective in preventing ischemic strokes in atrial fibrillation (AF) patients with risk factors.
  • Therapeutic anticoagulation with VKAs (INR 2-3) prevents over 50% of AF-related strokes with rare bleeding complications.
  • Regular monitoring is essential for VKAs due to their narrow therapeutic index; alternative causes should be investigated if stroke occurs despite anticoagulation.

Impact:

  • Effective anticoagulation management significantly reduces stroke incidence and improves patient outcomes in atrial fibrillation.
  • Well-controlled anticoagulation offers a favorable risk-benefit profile, preventing major disability from stroke.
  • Emerging anticoagulants may offer improved safety and convenience for stroke prevention in atrial fibrillation.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...